KSQ Therapeutics Receives FDA Clearance to Advance CRISPR-Edited Cell Therapy for Advanced Solid Tumors Next-generation gene editing powers new hope for hard-to-treat solid tumors in early human trials. 2 years ago By Ana In Biopharma Highlights,Breakthroughs,Clinical Trials,FDA Approvals,Top Stories,
